نتایج جستجو برای: daunorubicin

تعداد نتایج: 2644  

Journal: :Biochemical Society transactions 1978
W S Stevely C J Packard

decreased until the beat rate was apparentlyrestored to near-normal, all waves then being of reduced amplitude. The mean pressure gradually declined. This progressive loss of contractile force preceded complete cessation of work within 90min in hearts which were not terminated experimentally within this time. Normal concentrations of ATP and phosphocreatine were maintained despite the work fail...

2010
Hee-Jeong Ahn Im-Sook Song

− P-gp plays a critical role in drug disposition and represents a mechanism for the development of multidrug resistance. Flavonoids, a major class of natural compounds widely present in foods and herbal products, have been shown to inhibit P-gp. Therefore, the aim of this study was to identify new candidate chemosensitizers by screening various plant extracts. The ability of natural plant extra...

Journal: :Molecular cancer therapeutics 2007
Suzanne M Cutts Lonnie P Swift Vinochani Pillay Robert A Forrest Abraham Nudelman Ada Rephaeli Don R Phillips

The anthracycline group of compounds is extensively used in current cancer chemotherapy regimens and is classified as topoisomerase II inhibitor. However, previous work has shown that doxorubicin can be activated to form DNA adducts in the presence of formaldehyde-releasing prodrugs and that this leads to apoptosis independently of topoisomerase II-mediated damage. To determine which anthracycl...

Journal: :Archives of Disease in Childhood 1972

2011
Jingyuan Li Chen Chen Xuemei Wang Zhongze Gu Baoan Chen

Poly (lactic acid) (PLA) polymer has the promising applications in the biomedical field because of its biodegradability and safe elimination. In this study, we have explored the bio-application of new nanocomposites composed with PLA nanofibers and Au nanoparticles as the potential drug carrier for an efficient drug delivery in target cancer cells. The results demonstrated that the anticancer d...

Journal: :Cancer research 1982
S Seeber R Osieka C G Schmidt W Achterrath S T Crooke

From a single wild-type strain of Ehrlich ascites tumor, sublines resistant to daunorubicin, etoposide, and cis-diamminedichloroplatinum(II) have been developed in vivo. Different levels of resistance were achieved after 4 to 8 months for anthracyclines (greater than 32-fold), cis-diamminedichloroplatinum(II) (4-fold), and etoposide (greater than 6-fold). Anthracycline resistance was associated...

2014
Adolfo Quiñones-Lombraña Daniel Ferguson Rachael Hageman Blair James L. Kalabus Almedina Redzematovic Javier G. Blanco

Purpose The intracardiac synthesis of anthracycline alcohol metabolites (e.g., daunorubicinol) contributes to the pathogenesis of anthracycline-related cardiotoxicity. Cancer patients with Down syndrome (DS) are at increased risk for anthracycline-related cardiotoxicity. We profiled the expression of anthracycline metabolizing enzymes in hearts from donors withand withoutDS. Methods Cardiac exp...

Journal: :Cancer research 1977
R Supino A Necco T Dasdia A M Casazza A Di Marco

Four new derivatives of daunorubicin and two new derivatives of Adriamycin characterized by the absence of the methoxyl groups at the C-4 position have been studied in cell cultures in vitro to establish structure-activity relationships. 4-Demethoxydaunorubicin was 27 to 100 times more active than was daunorubicin when inhibiting the cloning efficiency of exponential-phase HeLa cells and, like ...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009
Franco Mandelli Marco Vignetti Stefan Suciu Roberto Stasi Maria-Concetta Petti Giovanna Meloni Petra Muus Filippo Marmont Jean-Pierre Marie Boris Labar Xavier Thomas Francesco Di Raimondo Roel Willemze Vincenzo Liso Felicetto Ferrara Liliana Baila Paola Fazi Robert Zittoun Sergio Amadori Theo de Witte

PURPOSE To compare the antitumor efficacy of three different anthracyclines in combination with cytarabine and etoposide in adult patients with newly diagnosed acute myeloid leukemia (AML). PATIENTS AND METHODS We randomly assigned 2,157 patients (age range, 15 to 60 years) to receive intensive induction-consolidation chemotherapy containing either daunorubicin, idarubicin, or mitoxantrone. A...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید